Let me know if you want to be added.
go.bsky.app/DtoXvaD
#Genitourinary #Oncology #GUonc #ProstateCancer #KidneyCancer #Urothelial #BladderCancer #PenileCancer #TesticularCancer #pcsm #kcsm #blcsm #tcsm #Medsky #Medtwitter
Let me know if you want to be added.
go.bsky.app/DtoXvaD
#Genitourinary #Oncology #GUonc #ProstateCancer #KidneyCancer #Urothelial #BladderCancer #PenileCancer #TesticularCancer #pcsm #kcsm #blcsm #tcsm #Medsky #Medtwitter
#bladdercancer #abcuk #urologynurse #nurseeducation
#bladdercancer #abcuk #urologynurse #nurseeducation
#BladderCancer #ctDNA #CancerResearch
✍️ #IRBBarcelona & University of Washington
➡️ bit.ly/42wcIN5
📌 DOI: 10.1038/s41586-025-09521-x
#IRBScience #CancerResearch #BladderCancer @bbglab.bsky.social
🧵👇
✍️ #IRBBarcelona & University of Washington
➡️ bit.ly/42wcIN5
📌 DOI: 10.1038/s41586-025-09521-x
#IRBScience #CancerResearch #BladderCancer @bbglab.bsky.social
🧵👇
And my friend @jackiebrownmd.bsky.social’s presentation on Emerging Perioperative Systemic Therapy for Urothelial Cancer at this year’s #BladderCancer course
@winshipatemory.bsky.social @emoryuroonc.bsky.social
And my friend @jackiebrownmd.bsky.social’s presentation on Emerging Perioperative Systemic Therapy for Urothelial Cancer at this year’s #BladderCancer course
@winshipatemory.bsky.social @emoryuroonc.bsky.social
Now cancer research is at risk.
🔻 NIH funding cuts
🔻 240+ grants canceled
🔻 Progress stalled
“If it can happen to Prime, it can happen to you.”
#BladderCancer #CancerFunding
Now cancer research is at risk.
🔻 NIH funding cuts
🔻 240+ grants canceled
🔻 Progress stalled
“If it can happen to Prime, it can happen to you.”
#BladderCancer #CancerFunding
Dr Eva Maria Compérat
Role of AI for diagnosis and monitoring #BladderCancer
Emphasizes the broad potential of AI in diagnosing and monitoring
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
Dr Eva Maria Compérat
Role of AI for diagnosis and monitoring #BladderCancer
Emphasizes the broad potential of AI in diagnosing and monitoring
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
#BladderCancer #Immunotherapy #Oncology @oncoalert.bsky.social
#BladderCancer #Immunotherapy #Oncology @oncoalert.bsky.social
✅ 3-year freedom from cystectomy: 88%
✅ 3-year OS: 69%
🔷monitoring is key.
#BladderCancer #Oncology
@oncoalert.bsky.social @oncbrothers.bsky.social
@achoud72.bsky.social
✅ 3-year freedom from cystectomy: 88%
✅ 3-year OS: 69%
🔷monitoring is key.
#BladderCancer #Oncology
@oncoalert.bsky.social @oncbrothers.bsky.social
@achoud72.bsky.social
#abcuk #bladdercancer #bladdercancerawareness #urologynurse
#abcuk #bladdercancer #bladdercancerawareness #urologynurse
#abcuk #nurseeducation #bladdercancer #urologynurse
#abcuk #nurseeducation #bladdercancer #urologynurse
#PublicHealth #medsky 👇
www.ema.europa.eu/en/news/meet...
#PublicHealth #medsky 👇
www.ema.europa.eu/en/news/meet...
#cancer #jcoprecisionmedicine #bladdercancer #guoncology #biomarker
oncodaily.com/insight/eman...
#BladderCancer #Cancer #GUMalignancies #Health #JCOPrecisionOncology #OncoDaily #Oncology #Medicine
#cancer #jcoprecisionmedicine #bladdercancer #guoncology #biomarker
✍️ #IRBBarcelona & University of Washington
📌 DOI: 10.1038/s41586-025-09521-x
Video credits: 3CatInfo, Som3cat
#IRBScience #CancerResearch #BladderCancer @bbglab.bsky.socialky.app/profile/did:plc:h4oarsknsugjli3piiechbzh" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky-mention">@bbglab.bsky.social
✍️ #IRBBarcelona & University of Washington
📌 DOI: 10.1038/s41586-025-09521-x
Video credits: 3CatInfo, Som3cat
#IRBScience #CancerResearch #BladderCancer @bbglab.bsky.socialky.app/profile/did:plc:h4oarsknsugjli3piiechbzh" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky-mention">@bbglab.bsky.social
#Oncology #BladderCancer
#Oncology #BladderCancer